Skip to main content
Caplight Logo









Regara

Regara

Private
Las Vegas, NevadaEnterprise Softwarehttps://regara.ai/

Last Round

Seed

Apr 11, 2026

Total Funding Raised

$400,000

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Regara operates in Enterprise Software and is based in Las Vegas, Nevada. Its latest recorded funding round was a Seed round in April 2026.

Regara is an AI-native operating system for life sciences regulatory affairs that automates the drafting and management of regulatory submissions for medical devices, drugs, and diagnostics.

Sector

Enterprise Software

Verticals

RegTech, Compliance & Risk, Vertical SaaS, Document Management, NLP & Conversational AI

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Regara Comparables

Compare Regara with similar companies based on industry and business-model similarity.

Regara comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AlphaLife Sciences
84%
RegDesk
82%
Kivo
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Regara Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 11, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Regara Investors

Notable investors and investment history

Regara investors
InvestorRounds
Nevada Battle Born Growth Escalator, Inc.Seed
AngelNVSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 11, 2026

    $400K round with AngelNV and Nevada Battle Born Growth Escalator

Book a demo to see all signals

For institutional investors. Book with your work email.

Regara Filings

Explore SEC and related filing metadata, where available.

Regara filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Regara's valuation, stock price, and market status.

Is Regara a public or private company?

Regara is a private company.

What is the current stock price of Regara?

Regara is a private company, so its shares have no public market price. Caplight tracks Regara's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Regara worth (valuation)?

Valuation information for Regara is not publicly available.

Can I buy Regara stock?

Regara shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Regara's last funding round?

Regara's most recent funding round was Seed on April 11, 2026.

Who are the main investors in Regara?

Key investors in Regara include Nevada Battle Born Growth Escalator, Inc., AngelNV.

Will Regara IPO soon?

No public IPO plans have been announced for Regara.

How can I track Regara secondary market activity?

Caplight tracks bids, offers, and trades in Regara's shares on secondary markets.

Firmographic Details

HeadquartersLas Vegas, Nevada
Year Founded2026
Last FundingApr 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?